Brought to you by:
MHRA announces UK medical device regulation amends
The Medicines and Healthcare products Regulatory Agency (MHRA) has today announced important new steps to secure access for patients to the latest medical technologies available in Europe and other advanced countries. As well as improving patient access to technologies, the…
‘Parenthood in vascular surgery a personal choice, not a professional deadline’
When is the right time to start a family in vascular surgery? That was a core question posed during the 2025 Vascular Annual Meeting (VAM) in New Orleans (June 4–7) in a dedicated session aimed at tackling issues around parenthood…
New SVS president seeks to enhance communication with members, tighten focus on outcomes
With another Vascular Annual Meeting (VAM) in the books, that means the flag unfurls on a new presidential year. And that means Philadelphia-based vascular surgeon Keith Calligaro, MD, now leads the Society for Vascular Surgery (SVS) as president. And Calligaro,…
SVS launches partnership to help private practice vascular surgeons cut costs
The Society for Vascular Surgery (SVS) has announced a new partnership with group purchasing organization (GPO) Provista in an effort to help provide a cost-slashing benefit to private practice physicians amid ongoing financial pressures in outpatient care. The initiative, unveiled…
Getinge’s iCast covered stent system approved as bridging stent in US
Getinge recently announced that it has received Food and Drug Administration (FDA) premarket approval (PMA) for the iCast covered stent system. The device is now available as a bridging stent for the treatment of patients with aneurysmal disease. Getinge states…
Danish study suggests patients with AAA could benefit from high-dose statin use
A five-year prospective cohort study—using longitudinal registry data from two population-based screening trials—has found that high-dose statin use was associated with decreased abdominal aortic aneurysm (AAA) growth rates and lowered risk of undergoing repair, rupture, and death. Researchers therefore suggest…
Medtronic enrols first patient in Onyx liquid embolic IDE clinical study
Medtronic today announced that the first patient has been enrolled in the Peripheral Onyx liquid embolic (PELE) clinical trial, which will evaluate the safety and effectiveness of the Onyx liquid embolic system (LES) for embolization of arterial hemorrhage in the…
Medtronic to distribute FMD’s peripheral guidewires for transradial access in US
Medtronic today announced it has entered into an exclusive U.S. distribution agreement with Japan-based Future Medical Design Co (FMD) to sell specialty and workhorse peripheral guidewires. This agreement includes the first 400cm, 0.018″ peripheral guidewire available in the U.S., expanding…
Cook announces US launch of Zenith iliac branch device
Cook Medical has announced that its Zenith iliac branch device (ZBIS) is now commercially available in the U.S. with Food and Drug Administration (FDA) approval as an endovascular treatment option for aortoiliac or iliac aneurysmal disease. The company has also…
Vascular surgery history: Putting specialty on the map in a broader sense
The people, discoveries, innovations and events that brought the vascular surgery profession to where it is today formed the bedrock of the subject matter for this year’s John Homans Lecture—“Who put the vascular in vascular surgery?”—at the 2025 Vascular Annual…